Sold by: Next Move Strategy Consulting
Deployed on AWS
The global Arterial Stents Market was valued at USD 16.18 billion in 2024 and is projected to reach USD 17.93 billion by 2025. By 2030, the market is expected to grow to USD 29.94 billion, reflecting a compound annual growth rate (CAGR) of 10.8%. This steady growth is primarily driven by the rising prevalence of cardiovascular diseases and the increasing preference for minimally invasive procedures aimed at restoring blood flow and preventing potentially life-threatening complications.
Overview
The global Arterial Stents Market is expected to grow to USD 29.94 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.8%. As cardiovascular diseases continue to be a leading cause of mortality worldwide, the demand for effective treatments such as arterial stents is growing rapidly. Arterial stents, which are small mesh-like tubes inserted into blocked or narrowed arteries, help keep the vessels open and ensure adequate blood circulation. The shift toward minimally invasive procedures, which offer shorter recovery times and reduced risks compared to traditional surgical methods, is further propelling the adoption of stenting technologies. With ongoing advancements in stent designs and materials, the market is expected to continue its upward trajectory in the coming years.
Download FREE Sample: https://www.nextmsc.com/arterial-stents-market-hc3570/request-sample
The growing global aging population is another key factor driving the demand for arterial stents. Elderly individuals are particularly vulnerable to chronic diseases, especially cardiovascular conditions like coronary artery disease, which often require stenting interventions to restore proper blood circulation. With longer life expectancies and a greater preference for minimally invasive solutions among older adults, the demand for innovative arterial stenting procedures continues to rise.
In addition to the aging population, the consistent increase in global healthcare expenditure is providing a strong foundation for the adoption of advanced medical technologies, including arterial stents. Governments and healthcare organizations worldwide are allocating greater budgets to enhance cardiovascular care infrastructure, enabling broader access to state-of-the-art treatment options. As health expenditure as a share of GDP has steadily grown over the past decade, there has been a growing commitment to improving healthcare outcomes. This financial growth is facilitating the procurement of advanced stent technologies, training for healthcare professionals, and the expansion of cardiovascular care facilities, further accelerating the expansion of the arterial stents market.
Inquire before buying: https://www.nextmsc.com/arterial-stents-market-hc3570/inquire-before-buying
A particularly promising innovation in this field is the advent of bioresorbable stents, which are expected to revolutionize cardiovascular treatments. Unlike traditional metallic stents, which remain permanently implanted, bioresorbable stents dissolve gradually within the body after restoring normal blood flow, leaving behind a naturally healed vessel. This advancement addresses several long-standing challenges associated with conventional stents, such as late-stage thrombosis, chronic inflammation, and the need for long-term dual antiplatelet therapy. With increasing demand for patient-friendly and minimally invasive treatment solutions, bioresorbable stents are poised to redefine the arterial stent landscape, offering safer outcomes, fewer post-procedure complications, and improved quality of life for patients.
Access full report: https://www.nextmsc.com/report/arterial-stents-market-hc3570
North America currently leads the arterial stents market and is expected to maintain its dominant position throughout the forecast period. This dominance is largely driven by rising healthcare spending in the U.S. and Canada, which supports the adoption of advanced cardiovascular treatment solutions. Increased funding allows healthcare providers to integrate cutting-edge stenting technologies, improve patient access to minimally invasive procedures, and enhance overall treatment outcomes for those suffering from cardiovascular diseases.
Key players in the arterial stents industry are actively expanding their global presence through strategic partnerships, brand launches, and service diversification. These efforts are helping to strengthen their market position, enhance their product offerings, and accelerate the adoption of arterial stents worldwide, ensuring the continued growth of the market.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider committed to delivering high-quality market research reports. We assist multinational companies in gaining a competitive edge and expanding their industry presence by capturing a larger market share. Our research methodology combines primary research, secondary research, data mining, and data analytics to deliver reliable insights.
Over a decade, we have served over 1,000 global customers, including 90% of Fortune 500 companies. Our analysts constantly monitor high-growth markets and uncover hidden opportunities in various sectors. We offer top-quality syndicate and custom research reports across ten different industry verticals, catering to your unique business needs. Our industry-standard delivery solutions, from pre-consultation to after-sales services, ensure an exceptional client experience and support informed strategic decision-making.
Contact Us:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: https://www.nextmsc.com/
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
This data package contains the data about the number of individuals and of the medical procedures undergone by the individuals in a year, procedures that can be categorized as cardiac diagnosis or treatment procedures. In this data package can be found useful statistics related to cardiac procedures, crude rates and the adjusted rates of procedures at Hospital Referral Region in most of the cases and for defibrillator insertion at State, Hospital Service Areas and County level also.
CAD-RADS stands for Coronary Artery Disease Reporting and Data System. It's a standardized method for reporting the results of coronary computed tomography angiography (CCTA). Cardiovascular disease (CVD) refers to a group of conditions that affect the heart and blood vessels. It is the leading cause of death globally, accounting for over 17 million deaths annually. Creating better tools for coronary artery disease with centerline segmentation, stenosis assessment. Utilize MPR and CMPR views.
A CCTA with FFR measurements refers to a coronary computed tomography angiography (CCTA) scan where the imaging data is analyzed to calculate a fractional flow reserve (FFR) value, essentially providing a non-invasive assessment of how well blood flows through coronary arteries, while a cath report with FFR measurements is a report from a cardiac catheterization procedure where FFR is directly measured using a catheter inserted into the coronary arteries.
This file is a 6 month sample including patients enrolled/active in the PINNACLE Registry in the six month time period of 1/1/2019 thru 6/30/2019.